 xxxd2000xxx  is beneficial in both fluctuating and non-fluctuating patients with parkinson's disease: a randomised, placebo controlled, double blind,...  to study the effect of  xxxd2000xxx , a specific peripherally acting  xxxg487xxx  (comt) inhibitor used in combination with levodopa treatment, in cases of parkinson's disease with both fluctuating and non-fluctuating response to treatment.